+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Facial Injectables Market - Growth, Trends, and Forecast (2019 - 2024)

  • ID: 4622515
  • Report
  • 113 pages
  • Mordor Intelligence
1 of 4


  • Allergan PLC
  • Anika Therapeutics Inc.
  • Ipsen SA
  • Medytox Inc.
  • Merz Pharma
  • Sanofi SA
  • MORE
Market Overview

The propelling factors for the growth of the facial injectables market include the rising aesthetic consciousness and number of cosmetic procedures, the introduction of cost-effective facial injectable, and the aging population.

The cosmetic industry is found to be booming in the current decade and has undergone an estimated three-fold increase in turnover over the last few decades. In particular, there has been an increase in the total number of non-surgical therapies, such as injections of wrinkle relaxers and dermal fillers. This trend is primarily due to the advantages of technologies, such as low recovery time, less risk of infections, no blood loss, and the overall reduction in procedural costs. Thus, the increase in the number of cosmetic procedures has spurred the growth of the overall market.

In addition, there is a consistent rise in the geriatric population that helps to boost the market growth. Along with the aging population, the new generation has been attracted to the cosmetic industry to appear more youthful. Furthermore, technological advancements are also helping in the growth of the market.

Scope of the Report

As per the scope of the report, facial injectables aid in rejuvenating the facial skin by reducing wrinkles, raising scar depressions, and enhancing the lips. Facial injectables are products that include collagen fillers, hyaluronic acid fillers, and synthetic fillers, such as calcium hydroxylapatite. The use of injectable products, such as hyaluronic acid increases skin hydration, improves skin, and protects from UV damage and has relatively low side effects. These factors are anticipated to drive the market growth over the forecast period.

Key Market Trends

Hyaluronic acid Holds the Largest Share in Dermal Fillers and is Expected to Continue During the Forecast Period

Hyaluronic acid holds the largest share in the market due to the increased usage of dermal fillers in aesthetic surgeries. Moreover, hyaluronic acid has major benefits as it increases hydration, improves elasticity, and reverses free radical damage that protects from UV damage. These factors help in driving the overall market for hyaluronic acid. It is also seen that the demand for hyaluronic acid is increasing significantly, which is expected to provide a consistent growth in the coming years in the studied market.

North America Region Holds the Largest Market Share and is Expected to Follow the Same Trend over the Forecast Period

North America is among the major dominating market for facial injectables, with the United States holding the largest market share in North America due to a higher awareness about aesthetic surgical procedures. There is also an increasing geriatric population and demand for non-invasive aesthetic procedures that help in driving the market studied over the forecast period.

Competitive Landscape

The key players present in the market are making collaborations and product launch strategies in order to address the unmet aesthetic needs. Thereby, providing the physicians with new and better options, as well as augmenting the growth of the facial injectables market. The companies are also focusing on expanding their presence in the emerging markets and also trying to maintain strong distributor relationships.
Note: Product cover images may vary from those shown
2 of 4


  • Allergan PLC
  • Anika Therapeutics Inc.
  • Ipsen SA
  • Medytox Inc.
  • Merz Pharma
  • Sanofi SA
  • MORE
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Aesthetic Consciousness and Number of Cosmetic Procedures
4.2.2 Introduction of Cost-effective Facial Injectable
4.2.3 Ageing Population
4.3 Market Restraints
4.3.1 Side-effects of Available Products Limiting Adoption
4.3.2 Lack of Reimbursement Policies Supporting Cosmetic Procedures
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Type
5.1.1 Wrinkle Relaxers Botulinum Toxin
5.1.2 Dermal Fillers Collagen Hyaluronic Acid Fat Injection Polylactic Acid Polymethyl-methacrylate Microspheres (PMMA) Calcium Hydroxylapatite Other Dermal Fillers (Polyalkylimide etc.)
5.2 By Application
5.2.1 Facial Line Correction
5.2.2 Lip Augmentation
5.2.3 Face Lift
5.2.4 Acne Scar Treatment
5.2.5 Lipoatrophy Treatment
5.2.6 Other Applications (Chin augmentation and Earlobe Rejuvenation etc.)
5.3 Geography
5.3.1 North America US Canada Mexico
5.3.2 Europe Germany UK France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Allergan PLC
6.1.2 Anika Therapeutics Inc.
6.1.3 Ipsen SA
6.1.4 Medytox Inc.
6.1.5 Merz Pharma
6.1.6 Nestle Skin Health (Galderma Pharma SA)
6.1.7 Sanofi SA
6.1.8 Sinclair Pharma PLC
6.1.9 Suneva Medical Inc.
6.1.10 Teoxane SA

Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • Allergan PLC
  • Anika Therapeutics Inc.
  • Ipsen SA
  • Medytox Inc.
  • Merz Pharma
  • Nestle Skin Health (Galderma Pharma SA)
  • Sanofi SA
  • Sinclair Pharma PLC
  • Suneva Medical Inc.
  • Teoxane SA
Note: Product cover images may vary from those shown